ABX Stock Analysis: Abacus Global Management | NYSE
Insurance - Life | NYSE, USA | Market Cap: 763m USD | 12M Return: 56.7% | US00258Y1047 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.91M
Qual. Beats: 0
Rev. Trend: 98.0%
Warnings
Tailwinds
Seasonality 6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Abacus Global Management, Inc. (NYSE: ABX) is a U.S.-based alternative asset manager and market maker with operations also in Luxembourg and other international markets. The company operates through three segments: Asset Management, Life Solutions, and Technology Services. The Asset Management segment provides investment services for alternative investments and exchange-traded funds (ETFs), the Life Solutions segment facilitates life insurance policy settlements between buyers and sellers, and the Technology Services segment offers contract-based services such as real-time mortality verification and missing participant verification specific to the life insurance industry. The company distributes its products through financial advisors, direct-to-consumer channels, and traditional life settlement intermediaries. Originally founded in 2004 as Abacus Life, Inc., the company was renamed Abacus Global Management, Inc. in February 2025 and is headquartered in Orlando, Florida.
Abacus is classified under the Financials sector, specifically within the Insurance Brokers sub-industry, reflecting its exposure to insurance-related services beyond traditional asset management. Its business model is relatively distinctive, combining an alternative asset management platform with a vertically integrated life settlement operation and proprietary technology services that support the broader life insurance market.
- Life settlements origination volume drives Life Solutions segment growth
- Alternative asset management AUM expansion boosts fee-based revenue
- Mortality verification technology contracts scale recurring services revenue
| Net Income: 28.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 25.64 > 1.0 |
| NWC/Revenue: 12.30% < 20% (prev -21.18%; Δ 33.48% < -1%) |
| CFO/TA 0.10 > 3% & CFO 90.8m > Net Income 28.2m |
| Net Debt (334.6m) to EBITDA (101.1m): 3.31 < 3 |
| Current Ratio: 1.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.8m) vs 12m ago 2.45% < -2% |
| Gross Margin: 68.55% > 18% (prev 88.21%; Δ -19.66% > 0.5%) |
| Asset Turnover: 31.15% > 50% (prev 19.06%; Δ 12.09% > 0%) |
| Interest Coverage Ratio: 2.16 > 6 (EBIT TTM 84.6m / Interest Expense TTM 39.2m) |
| A: 0.04 (Total Current Assets 75.3m - Total Current Liabilities 42.4m) / Total Assets 867.7m |
| B: -0.03 (Retained Earnings -27.9m / Total Assets 867.7m) |
| C: 0.10 (EBIT TTM 84.6m / Avg Total Assets 858.0m) |
| D: 1.03 (Book Value of Equity 439.7m / Total Liabilities 428.1m) |
| Altman-Z'' = 1.88 = BBB |
| DSRI: 1.22 (Receivables 51.9m/25.6m, Revenue 267.3m/161.7m) |
| GMI: 1.29 (GM 88.21% / 68.55%) |
| AQI: 1.03 (AQ_t 0.90 / AQ_t-1 0.87) |
| SGI: 1.65 (Revenue 267.3m / 161.7m) |
| TATA: -0.07 (NI 28.2m - CFO 90.8m) / TA 867.7m) |
| Beneish M = -2.10 (Cap -4..+1) = BB |
As of October 21, 2026, the stock is trading at USD 8.39 with a total of 899,721 shares traded. Over the past week, the price has changed by +3.33%, over one month by +4.22%, over three months by -18.23% and over the past year by +56.66%.
Current recommended Stop Loss: 8.00 (which is 4.6% or 1.2 ATR below the current price).
Abacus Global Management has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy ABX.
- StrongBuy: 4
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.1 | 67.8% |
P/E Trailing = 28.8889
P/E Forward = 10.5708
P/S = 2.8538
P/B = 1.7593
Revenue TTM = 267.3m USD
EBIT TTM = 84.6m USD
EBITDA TTM = 101.1m USD
Long Term Debt = 290.8m USD (from longTermDebt, last quarter)
Short Term Debt = 42.4m USD (from shortTermDebt, last quarter)
Debt = 358.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 13.7m
Net Debt = 334.6m USD (calculated: Debt 358.0m - CCE 23.4m)
Enterprise Value = 1.10b USD (762.8m + Debt 358.0m - CCE 23.4m)
Interest Coverage Ratio = 2.16 (Ebit TTM 84.6m / Interest Expense TTM 39.2m)
EV/FCF = 12.37x (Enterprise Value 1.10b / FCF TTM 88.7m)
FCF Yield = 8.09% (FCF TTM 88.7m / Enterprise Value 1.10b)
FCF Margin = 33.20% (FCF TTM 88.7m / Revenue TTM 267.3m)
Net Margin = 10.55% (Net Income TTM 28.2m / Revenue TTM 267.3m)
Gross Margin = 68.55% ((Revenue TTM 267.3m - Cost of Revenue TTM 84.1m) / Revenue TTM)
Gross Margin QoQ = 76.73% (prev 76.13%)
Tobins Q-Ratio = 1.26 (Enterprise Value 1.10b / Total Assets 867.7m)
Interest Expense / Debt = 10.95% (Interest Expense 39.2m / Debt 358.0m)
Taxrate = 37.85% (17.2m / 45.4m)
NOPAT = 52.6m (EBIT 84.6m * (1 - 37.85%))
Current Ratio = 1.77 (Total Current Assets 75.3m / Total Current Liabilities 42.4m)
Debt / Equity = 0.81 (Debt 358.0m / totalStockholderEquity, last quarter 439.7m)
Debt / EBITDA = 3.31 (Net Debt 334.6m / EBITDA 101.1m)
Debt / FCF = 3.77 (Net Debt 334.6m / FCF TTM 88.7m)
Total Stockholder Equity = 430.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.29% (Net Income 28.2m / Total Assets 867.7m)
RoE = 6.56% (Net Income TTM 28.2m / Total Stockholder Equity 430.1m)
RoCE = 11.73% (EBIT 84.6m / Capital Employed (Equity 430.1m + L.T.Debt 290.8m))
RoIC = 6.15% (NOPAT 52.6m / Invested Capital 854.4m)
WACC = 6.84% (E(762.8m)/V(1.12b) * Re(6.85%) + D(358.0m)/V(1.12b) * Rd(10.95%) * (1-Tc(0.38)))
Discount Rate = 6.85% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 90.99 | Cagr: 22.64%
[DCF] Terminal Value 75.44% ; FCFF base≈88.7m ; Y1≈89.1m ; Y5≈94.4m
[DCF] Fair Price = 11.59 (EV 1.47b - Net Debt 334.6m = Equity 1.13b / Shares 97.8m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.20 | # QB: 0
Revenue Correlation: 98.05 | Revenue CAGR: 91.00% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.27 | Chg30d=+3.19% | Revisions=+17% | Analysts=6
EPS current Year (2026-12-31): EPS=1.04 | Chg30d=+2.13% | Revisions=+25% | GrowthEPS=+21.1% | GrowthRev=+22.1%
EPS next Year (2027-12-31): EPS=1.19 | Chg30d=+3.47% | Revisions=+0% | GrowthEPS=+14.4% | GrowthRev=+17.6%
[Analyst] Revisions Ratio: +22% (up=4, down=2)